Ophthotech Provides Update on Zimura® Complement Programs for Treatment of Eye Diseases

NEW YORK--(BUSINESS WIRE)--Ophthotech announced the initiation of an open-label Phase 2a clinical trial of Zimura® in patients with wet age-related macular degeneration (AMD)

Full Story →